Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity.
about
Preclinical evidences toward the use of triterpenoid CDDO-Me for solid cancer prevention and treatmentThe dual role of complement in cancer and its implication in anti-tumor therapyGenetics and biology of pancreatic ductal adenocarcinomaCancer immunotherapy for pancreatic cancer utilizing α-gal epitope/natural anti-Gal antibody reactionTargeting Epigenetic Processes in Photodynamic Therapy-Induced Anticancer ImmunityMyeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implicationsStem cell technology for bone regeneration: current status and potential applicationsMesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumorSurgical Stress Abrogates Pre-Existing Protective T Cell Mediated Anti-Tumor Immunity Leading to Postoperative Cancer RecurrenceThe Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer ProgressionTargeted immune therapy of ovarian cancerCeramide mediates FasL-induced caspase 8 activation in colon carcinoma cells to enhance FasL-induced cytotoxicity by tumor-specific cytotoxic T lymphocytesMIF: metastasis/MDSC-inducing factor?Immunotherapy for recurrent ovarian cancer: a further piece of the puzzle or a striking strategy?Continuous retinoic acid induces the differentiation of mature regulatory monocytes but fails to induce regulatory dendritic cellsThe innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy.The receptor for advanced glycation end products promotes pancreatic carcinogenesis and accumulation of myeloid-derived suppressor cells.Myeloid cells in circulation and tumor microenvironment of breast cancer patientsParadoxical myeloid-derived suppressor cell reduction in the bone marrow of SIV chronically infected macaques.Immunosuppressive myeloid cells induced by chemotherapy attenuate antitumor CD4+ T-cell responses through the PD-1-PD-L1 axisCharacterization of the MDSC proteome associated with metastatic murine mammary tumors using label-free mass spectrometry and shotgun proteomicsMurine pancreatic adenocarcinoma dampens SHIP-1 expression and alters MDSC homeostasis and functionMyeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patientsOpposing roles for complement component C5a in tumor progression and the tumor microenvironment.Targeting CD8+ T-cell tolerance for cancer immunotherapy.Identification of myeloid derived suppressor cells in the peripheral blood of tumor bearing dogs.IL-6-stimulated CD11b+ CD14+ HLA-DR- myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus.Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment.The consequence of immune suppressive cells in the use of therapeutic cancer vaccines and their importance in immune monitoringA circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patientsCirculating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma.Proteomic pathway analysis reveals inflammation increases myeloid-derived suppressor cell resistance to apoptosisVaccines targeting the neovasculature of tumorsSystemic delivery of neutralizing antibody targeting CCL2 for glioma therapy.Natural history of tumor growth and immune modulation in common spontaneous murine mammary tumor modelsStromal-dependent tumor promotion by MIF family members.MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy.Oncolytic herpes simplex virus 1 encoding 15-prostaglandin dehydrogenase mitigates immune suppression and reduces ectopic primary and metastatic breast cancer in mice.Immunity and immune suppression in human ovarian cancer.Myxomaviral Anti-Inflammatory Serpin Reduces Myeloid-Derived Suppressor Cells and Human Pancreatic Cancer Cell Growth in Mice
P2860
Q21245749-3D068232-15BF-4ABB-A00E-F6265793218CQ26738682-912A580B-D2F5-4D3B-A8E1-74F7B78006BDQ26765438-46D1D695-04F9-467C-A3A5-281563D3DE5EQ26777542-43D9AF83-0EF9-4FAC-9565-16D8B8CF4FCFQ26797280-5C3CBE8E-37F0-4CC5-BB99-9E01DBC4380CQ27014189-5301122D-5296-469B-B169-B892B8F1AFD4Q27015888-199652D5-111A-4091-AC90-534D524C5D76Q27320784-C5675AA9-4013-4F38-B948-DBB7209A0A0BQ27345519-4D06BE41-EAB4-4574-B4E6-C96D5486E5FEQ28076760-FADF47C1-CE43-4467-8724-5F34B6D2E674Q28082828-F9C21BCE-285E-493C-8936-E5633EC35452Q30357159-E8AA75FD-A673-4A40-8CB7-400EBE39A893Q30418662-99F4A005-76B2-4D6F-ADCF-F04AA2482186Q33357295-4FBC965D-3CE4-4F1C-8119-45BC5A8C6689Q33592420-876EA0DE-32BE-48A8-80B6-9EDDFAFCF036Q33660069-E0003F15-723A-4845-87ED-59470212891AQ33709243-BA6A939F-014B-4635-AE7B-6FB8463A7A72Q33729434-80439759-BF05-45C4-BDB8-22DD7A97DD1FQ33739465-BBE904C4-8D49-4BE2-86AB-CBAA22D36E46Q33838944-1A1E0452-EC2C-417C-BB85-EC42103F9554Q33996767-5E2E4F53-F171-4DFC-B3AB-5078688CF7B3Q34087816-92C8F71F-93D5-4283-B593-A9210F731126Q34250873-43428A2C-426A-4AC0-8FA9-0BEBFA943CCBQ34295401-E51BF6E6-CB22-4DD1-BB21-36464CCC600AQ34432692-1D7A55FC-AA06-416A-852F-50282D22E833Q34461732-32CE9027-1574-43CA-B8E6-640CE3F88314Q34483744-EAF5D3BC-2A77-495A-A730-E7BDDB38904CQ34502899-A0335D63-905B-437E-875A-31B5F7240CD6Q34557531-0865B8A2-15A4-42CB-8B7A-A2EF3366D12FQ34570094-A255BC3D-2970-42FD-A286-CC04DF0C12D5Q34600087-EEF7466D-BC68-47D6-B694-775ECF30C55FQ34616787-CF00D722-523D-4711-B592-30E1591E134EQ34704905-7B6611EA-50CD-47AD-AC86-9902063941C0Q34744555-AF5702AA-2F59-4E7C-BC1A-CDAAB926C683Q34789746-595069C7-F79C-4A69-9F72-451D9AAFF8BAQ34944820-302CA779-1393-439A-84AD-C00417F13684Q35028389-3FC4EC43-B12E-4364-BA42-32890C35C820Q35077655-0FC66B03-F21B-4BB6-B888-6BA535442206Q35138135-05ED81A5-5A70-47BF-B42F-3991A9AB6003Q35200102-3995DAC8-709D-4DFF-A384-F108B0C0C3FA
P2860
Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity.
@en
type
label
Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity.
@en
prefLabel
Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity.
@en
P2860
P1476
Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity.
@en
P2093
Suzanne Ostrand-Rosenberg
P2860
P2888
P304
P356
10.1007/S00262-010-0855-8
P577
2010-04-23T00:00:00Z